Summary

Computed tomography (CT) is the gold standard for assessing lymphoma response to therapy. This session addressed the role of imaging in guiding the treatment of patients with Hodgkin lymphoma and non-Hodgkin lymphoma, with a focus on the use of positron emission tomography/CT for response evaluation.